Skip to main content

Table 6 ADME parameters of synthesized compounds

From: Design, synthesis, in silico studies and biological evaluation of 5-((E)-4-((E)-(substituted aryl/alkyl)methyl)benzylidene)thiazolidine-2,4-dione derivatives

Comp.

ADME parameters

Mol MW

Rule of Five

QPlogPo/w

Human Oral Absorption

Volume

% Human Oral Absorption

QPlogPw

QPlogKp

QPlogBB

Donor HB

Accept HB

1

308.354

0

3.38

3

957.885

100.0

8.709

− 1.987

− 0.778

1.0

4.0

2

247.271

0

0.656

3

743.851

67.916

11.506

− 4.204

− 1.339

3.0

5.0

3

323.369

0

2.789

3

999.18

91.672

11.575

− 2.168

− 1.011

2.0

5.5

4

342.799

0

3.817

3

995.909

100.0

8.468

− 2.092

− .0.613

1.0

4.0

5

342.799

0

3.871

3

1001.91

100.0

8.469

− 2.155

− 0.631

1.0

4.0

6

312.342

0

2.331

3

947.57

91.759

9.026

− 2.078

− 0.808

1.0

5.0

7

322.381

0

3.687

3

1017.578

100.0

8.404

− 2.183

− 0.813

1.0

4.0

8

322.381

0

3.688

3

1017.852

100.0

8.405

− 2.184

− 0.814

1.0

4.0

9

336.408

0

3.986

3

1072.652

100.0

8.091

− 2.333

− 0.807

1.0

4.0

10

336.408

0

3.958

3

1063.481

100.0

8.109

− 2.259

− 0.758

1.0

4.0

11

326.344

0

3.583

3

971.486

100.0

8.509

− 2.081

− 0.674

1.0

4.0

12

387.25

0

3.949

3

1010.987

100.0

8.477

− 2.157

− 0.622

1.0

4.0

13

353.352

0

2.681

3

1031.006

77.031

9.831

− 3.889

− 1.84

1.0

5.0

14

387.797

0

3.239

3

1073.076

82.122

9.524

− 3.85

− 1.579

1.0

5.0

15

338.38

0

3.509

3

1036.846

100.0

8.946

− 2.059

− 0.866

1.0

4.75

16

338.38

0

3.475

3

1032.883

100.0

8.937

− 2.085

− 0.869

1.0

4.75

17

338.38

0

3.477

3

1033.285

100.0

8.943

− 2.086

− 0.872

1.0

4.75

18

326.344

0

3.615

3

974.01

100.0

8.488

− 2.121

− 0.674

1.0

4.0

19

353.352

0

2.677

3

1030.425

77.006

9.824

− 3.892

− 1.835

1.0

5.0

20

400.578

0

5.921

1

1434.834

100.0

6.164

− 1.791

− 1.671

1.0

4.5